Hedge fund giant Bridgewater Associates placed a new bet on EV maker Tesla Inc. late last year, as it exited memory chip maker Micron Technology and banking giant Goldman Sachs. The latest 13-F filing ...

The world’s biggest hedge fund made a fresh bet on EV maker Tesla Inc. late last year, as it exited memory chip maker Micron ...

The company is now expecting 2025 revenue to range from $1.5 billion to $2.5 billion, with a midpoint of $2.0 billion, while FactSet is expecting $2.4 billion. Most of that will come in the second ...

Goldman Sachs CEO David Solomon was awarded an $80 million stock bonus to stay at the helm for another five years, a stark turnaround for a leader whose survival was questioned after the firm's ...

Moderna, Inc. (NASDAQ:MRNA) is set to release its fourth-quarter earnings on Friday before the opening bell. Here's a look at ...

Moderna's Q4 earnings due Feb 14: analysts predict revenue decline & $2.73 loss. Explore vaccine demand, pipeline prospects, and stock outlook.

Moderna (NASDAQ:MRNA – Get Free Report) is expected to be issuing its quarterly earnings data before the market opens on Friday, February 14th. Analysts expect the company to announce earnings of ($2.

Moderna shares extended losses posted last week after Goldman Sachs downgraded the vaccine maker's stock, citing high ...

The S&P 500 Index ( $SPX) ( SPY) today is down -0.95%, the Dow Jones Industrials Index ( $DOWI ) ( DIA) is down -0.51%, and the Nasdaq 100 Index ( $IUXX) ( QQQ) is down -1.12%. March E-mini S&P ...

President Vladimir Putin is allowing Goldman Sachs Group Inc. to sell its business in Russia, making the US firm one of the few Western banks to fully exit the country. Putin permitted Balchug ...

Pharmaceutical giant Moderna, Inc. (NASDAQ:MRNA) saw its share prices drop by 9.39 percent on Wednesday to close at $40.72 each after investment banking firm Goldman Sachs downgraded Moderna’s ...

Pharmaceutical giant Moderna, Inc. (NASDAQ:MRNA) saw its share prices drop by 9.39 percent on Wednesday to close at $40.72 each after investment banking firm Goldman Sachs downgraded Moderna’s outlook ...